NASDAQ:RAPP | Cash Flow Statement | Rapport Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$56.62M
2026-03-31-$19.86M$227,000.00-$13.06M$86,000.00$37.94M$531,000.00
2025-12-31-$33.76M$265,000.00-$24.7M$169,000.00-$174.32M$311,000.00
2025-09-30-$26.93M
2025-06-30-$26.73M
2025-03-31-$24.06M$244,000.00-$20.24M$291,000.00$21.03M$5,000.00
2024-12-31-$19.98M$260,000.00-$14.45M$226,000.00$31.93M$7,000.00
2024-09-30-$17.54M
2024-06-30-$18.12M
2024-03-31-$22.67M$152,000.00-$17.62M$1.07M-$41.93M$63.66M
2023-12-31-$13.52M$53,000.00-$10.36M$1.44M-$78.66M-$140,000.00
2023-09-30-$8.71M
2023-06-30-$6.41M
2023-03-31-$6.15M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$111.48M$1.02M-$87.47M$616,000.00-$187.47M$270.79M
2024-12-31-$78.31M$839,000.00-$64.83M$2.41M-$170.14M$221.63M
2023-12-31-$34.79M$112,000.00-$27.18M$1.64M-$78.86M$145.14M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.